查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532825

細胞和基因治療製造服務市場，按治療類型、按細胞類型、按服務類型、按最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Cell and Gene Therapy Manufacturing Services Market, By Therapy Type, By Cell Type, By Service Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年，細胞和基因治療製造服務市場規模為 59.77 億美元，2024 年至 2032 年複合年成長率為 17.2%。

細胞與基因治療製造服務市場-市場動態

遺傳性疾病和癌症的日益普及推動了對細胞和基因治療製造服務的需求

遺傳性疾病和癌症的盛行率日益增加，大大推動了對細胞和基因治療製造服務的需求。例如，美國國家癌症研究所報告稱，預計 2024 年僅美國就會新增近 190 萬癌症病例，凸顯了對先進治療解決方案的迫切需求。同樣，世界衛生組織指出，全球約有二十分之一的人患有遺傳性疾病，增加了對專門治療的需求。最近在這一領域的投資引人注目，美國國立衛生研究院去年為基因療法研究撥款超過 10 億美元。此外，諾華（Novartis）和藍鳥生物（Bluebird Bio）等領先公司已經擴大了其製造能力，以滿足對這些尖端治療不斷成長的需求，這反映出人們越來越關注透過創新療法改善患者的治療結果。

細胞和基因治療製造服務市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 17.2% 左右的複合年成長率成長

根據治療類型細分，預計基因治療將在 2023 年顯示最大的市場佔有率

根據細胞類型細分，自體細胞是2023年的主導類型

根據服務類型細分，合約開發和製造組織（CDMO）是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

細胞與基因治療製造服務市場-細分分析：

全球細胞和基因治療製造服務市場根據治療類型、細胞類型、服務類型、最終用戶和地區進行細分。

根據治療類型，市場分為兩類：細胞治療和基因治療。細胞療法專注於用於治療用途的細胞的生產和操作，而基因療法則涉及開發改變遺傳物質以治療疾病的療法。

市場依細胞類型分為兩類：自體細胞和異體細胞。自體細胞來自患者自身，確保了相容性，而同種異體細胞則來自捐贈者，具有更廣泛的應用潛力。

細胞和基因治療製造服務市場 - 地理洞察

北美，尤其是美國，由於其先進的研究基礎設施、大量資金和強大的專業製造設施網路而引領市場。在歐洲，德國和英國等國家也是重要的參與者，受益於強力的監管框架以及生物技術公司與研究機構之間日益加強的合作。同時，亞太地區正在迅速崛起，中國和日本等國家大力投資生物技術創新並擴大其製造能力。例如，中國最近在基因治療基礎設施上投資了 5 億美元，這反映出它越來越注重成為該領域的主要參與者。

細胞與基因療法製造服務市場-競爭格局：

Lonza、Catalent 和 WuXi AppTec 等主要參與者憑藉廣泛的製造能力和全球影響力佔據市場主導地位，提供從細胞處理到基因編輯的一系列服務。這些公司得到了對尖端技術和戰略合作夥伴關係的大量投資的支持。例如，龍沙與諾華合作提高CAR-T細胞療法的生產能力，凸顯了深化產業聯盟的趨勢。新興生物技術公司和合約製造組織 (CMO) 也發揮著至關重要的作用，提供專業服務並推動創新。競爭環境的特點是技術不斷進步、監管適應以及對可擴展和高效製造解決方案的重視。

最新進展：

2024年5月，ProPharma與PBL合作推出了細胞工廠盒（CF Box），這是一種全自動封閉式細胞工廠設備，專為細胞和基因療法（CGT）的生產而設計。 CF Box 有助於在 D 級 (ISO8) 或受控非機密環境中分散製造各種 CGT。

2024 年 5 月，百時美施貴寶與 Cellares 簽署了價值 3.8 億美元的協議，生產 CAR T 細胞療法，突顯了對外包細胞和基因療法製造服務的需求不斷成長。 Cellares 計劃擴大在美國、歐洲和日本的自動化製造工廠。

目錄

第1章：細胞與基因治療製造服務市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按治療類型分類的細胞和基因治療製造服務市場片段
    • 按細胞類型分類的細胞和基因治療製造服務市場片段
    • 按服務類型分類的細胞和基因治療製造服務市場片段
    • 最終用戶的細胞和基因治療製造服務市場片段
    • 按國家/地區分類的細胞和基因治療製造服務市場片段
    • 按地區分類的細胞和基因治療製造服務市場片段
  • 競爭洞察

第 3 章：細胞和基因治療製造服務主要市場趨勢

  • 細胞和基因治療製造服務市場促進因素
    • 市場促進因素的影響分析
  • 細胞和基因治療製造服務市場限制
    • 市場限制影響分析
  • 細胞和基因治療製造服務市場機會
  • 細胞和基因治療製造服務市場未來趨勢

第 4 章：細胞與基因治療製造服務業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：細胞與基因治療製造服務市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：細胞與基因療法製造服務市場格局

  • 2023 年細胞和基因治療製造服務市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：細胞和基因治療製造服務市場 - 按治療類型

  • 概述
    • 按治療類型分類的細分市場佔有率分析
    • 細胞療法
    • 基因治療

第 8 章：細胞和基因治療製造服務市場 - 按細胞類型

  • 概述
    • 按電池類型分類的細分市場佔有率分析
    • 自體細胞
    • 同種異體細胞

第 9 章：細胞和基因治療製造服務市場 - 按服務類型

  • 概述
    • 按服務類型分類的細分市場佔有率分析
    • 合約開發與製造組織 (CDMO)
    • 合約研究組織（CRO）
    • 製造技術解決方案

第 10 章：細胞和基因治療製造服務市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥公司
    • 生技公司
    • 學術機構
    • 研究機構

第 11 章：細胞和基因療法製造服務市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 細胞和基因治療製造服務北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按治療類型）
    • 北美市場規模和預測（按電池類型）
    • 北美市場規模和預測（按服務類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 細胞和基因治療製造服務歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按治療類型）
    • 歐洲市場規模和預測（按電池類型）
    • 歐洲市場規模和預測（按服務類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 細胞和基因治療製造服務亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按治療類型）
    • 亞太地區市場規模和預測（按電池類型）
    • 亞太地區市場規模與預測（按服務類型）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 細胞和基因治療製造服務拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按治療類型）
    • 拉丁美洲市場規模和預測（按電池類型）
    • 拉丁美洲市場規模和預測（按服務類型）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 細胞和基因治療製造服務中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模和預測（按治療類型）
    • 中東和非洲市場規模及預測（按電池類型）
    • 中東和非洲市場規模及預測（按服務類型）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 細胞和基因治療製造服務產業

  • 競爭儀表板
  • 公司簡介
    • Adaptimmune Therapeutics plc
    • Bluebird Bio, Inc.
    • Catalent, Inc.
    • Celyad Oncology SA
    • Charles River Laboratories International, Inc.
    • Gene Therapy Research Group
    • Kiadis Pharma NV
    • Lonza Group AG
    • MaxCyte, Inc.
    • Miltenyi Biotec GmbH
    • Orchard Therapeutics plc
    • Rocket Pharmaceuticals, Inc.
    • Sangamo Therapeutics, Inc.
    • Sarepta Therapeutics, Inc.
    • TCR2 Therapeutics Inc.
    • WuXi AppTec
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3413

REPORT HIGHLIGHT

Cell and Gene Therapy Manufacturing Services Market size was valued at USD 5,977 Million in 2023, expanding at a CAGR of 17.2% from 2024 to 2032.

The Cell and Gene Therapy Manufacturing Services Market encompasses specialized services for the production of cell and gene therapies, which are revolutionary treatments targeting genetic disorders and various diseases. The rising prevalence of genetic disorders and cancer, coupled with advancements in personalized medicine, is fueling the market's expansion. However, challenges such as high production costs and complex regulatory requirements act as significant restraints. Opportunities are emerging in the form of increased investments in research and development, with global funding for cell and gene therapies having surged by approximately 30% in the past year. Additionally, partnerships between biotech firms and contract manufacturing organizations (CMOs) are on the rise, aiming to streamline production processes and enhance scalability.

Cell and Gene Therapy Manufacturing Services Market- Market Dynamics

Growing Prevalence of Genetic Disorders and Cancer Fuels Need for Cell and Gene Therapy Manufacturing Services

The increasing prevalence of genetic disorders and cancer is significantly driving the demand for Cell and Gene Therapy Manufacturing Services. For instance, the National Cancer Institute reports that nearly 1.9 million new cancer cases were expected in the U.S. alone in 2024, underscoring the urgent need for advanced therapeutic solutions. Similarly, the World Health Organization notes that genetic disorders affect about 1 in 20 people globally, amplifying the need for specialized therapies. Recent investments in this field have been notable, with the National Institutes of Health allocating over $1 billion in grants for gene therapy research in the past year. Additionally, leading companies like Novartis and Bluebird Bio have expanded their manufacturing capabilities to meet the rising demand for these cutting-edge treatments, reflecting a growing focus on improving patient outcomes through innovative therapies.

Cell and Gene Therapy Manufacturing Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.2% over the forecast period (2024-2032)

Based on Therapy Type segmentation, Gene Therapy was predicted to show maximum market share in the year 2023

Based on Cell Type segmentation, Autologous Cells was the leading type in 2023

Based on Service Type segmentation, Contract Development and Manufacturing Organization (CDMO) was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cell and Gene Therapy Manufacturing Services Market- Segmentation Analysis:

The Global Cell and Gene Therapy Manufacturing Services Market is segmented based on Therapy Type, Cell Type, Service Type, End-User, and Region.

The market is divided into two categories based on Therapy Type: Cell Therapy and Gene Therapy. Cell Therapy focuses on the production and manipulation of cells for therapeutic use, while Gene Therapy involves the development of treatments that alter genetic material to address diseases.

The market is divided into two categories based on Cell Type: Autologous Cells and Allogeneic Cells. Autologous Cells are derived from the patient's own body, ensuring compatibility, while Allogeneic Cells are sourced from donors and offer broader application potential.

Cell and Gene Therapy Manufacturing Services Market- Geographical Insights

North America, particularly the United States, leads the market due to its advanced research infrastructure, substantial funding, and a robust network of specialized manufacturing facilities. In Europe, countries such as Germany and the United Kingdom are also significant players, benefiting from strong regulatory frameworks and increasing collaboration between biotech companies and research institutions. Meanwhile, the Asia-Pacific region is emerging rapidly, with countries like China and Japan investing heavily in biotech innovations and expanding their manufacturing capabilities. For example, China's recent $500 million investment in gene therapy infrastructure reflects its growing focus on becoming a major player in this sector.

Cell and Gene Therapy Manufacturing Services Market- Competitive Landscape:

Key players such as Lonza, Catalent, and WuXi AppTec dominate the market with extensive manufacturing capabilities and global reach, providing a range of services from cell processing to gene editing. These companies are bolstered by significant investments in cutting-edge technologies and strategic partnerships. For instance, Lonza's collaboration with Novartis to enhance manufacturing capacity for CAR-T cell therapies highlights the trend towards deepening industry alliances. Emerging biotech firms and contract manufacturing organizations (CMOs) also play a crucial role, offering specialized services and driving innovation. The competitive environment is characterized by continuous advancements in technology, regulatory adaptations, and an emphasis on scalable and efficient manufacturing solutions.

Recent Developments:

In May 2024, ProPharma, in collaboration with PBL, introduced the Cell Factory Box (CF Box), a fully automated and enclosed cell factory device designed for the production of cell and gene therapies (CGTs). The CF Box facilitates decentralized manufacturing of various CGTs within Class D (ISO8) or controlled, non-classified environments.

In May 2024, Bristol Myers Squibb signed a USD 380 million deal with Cellares to produce CAR T-cell therapies, highlighting the rising demand for outsourced cell and gene therapy manufacturing services. Cellares plans to expand its automated manufacturing units in the US, Europe, and Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Adaptimmune Therapeutics plc

Bluebird Bio, Inc.

Catalent, Inc.

Celyad Oncology SA

Charles River Laboratories International, Inc.

Gene Therapy Research Group

Kiadis Pharma N.V.

Lonza Group AG

MaxCyte, Inc.

Miltenyi Biotec GmbH

Orchard Therapeutics plc

Rocket Pharmaceuticals, Inc.

Sangamo Therapeutics, Inc.

Sarepta Therapeutics, Inc.

TCR2 Therapeutics Inc.

WuXi AppTec

Others

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cell Therapy
  • Gene Therapy

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Autologous Cells
  • Allogeneic Cells

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Contract Development and Manufacturing Organization (CDMO)
  • Contract Research Organization (CRO)
  • Manufacturing Technology Solutions

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutions
  • Research Institutions

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell and Gene Therapy Manufacturing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell and Gene Therapy Manufacturing Services Market Snippet by Therapy Type
    • 2.1.2. Cell and Gene Therapy Manufacturing Services Market Snippet by Cell Type
    • 2.1.3. Cell and Gene Therapy Manufacturing Services Market Snippet by Service Type
    • 2.1.4. Cell and Gene Therapy Manufacturing Services Market Snippet by End-User
    • 2.1.5. Cell and Gene Therapy Manufacturing Services Market Snippet by Country
    • 2.1.6. Cell and Gene Therapy Manufacturing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell and Gene Therapy Manufacturing Services Key Market Trends

  • 3.1. Cell and Gene Therapy Manufacturing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell and Gene Therapy Manufacturing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell and Gene Therapy Manufacturing Services Market Opportunities
  • 3.4. Cell and Gene Therapy Manufacturing Services Market Future Trends

4. Cell and Gene Therapy Manufacturing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell and Gene Therapy Manufacturing Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell and Gene Therapy Manufacturing Services Market Landscape

  • 6.1. Cell and Gene Therapy Manufacturing Services Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell and Gene Therapy Manufacturing Services Market - By Therapy Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy Type, 2023 & 2032 (%)
    • 7.1.2. Cell Therapy
    • 7.1.3. Gene Therapy

8. Cell and Gene Therapy Manufacturing Services Market - By Cell Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
    • 8.1.2. Autologous Cells
    • 8.1.3. Allogeneic Cells

9. Cell and Gene Therapy Manufacturing Services Market - By Service Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 9.1.2. Contract Development and Manufacturing Organization (CDMO)
    • 9.1.3. Contract Research Organization (CRO)
    • 9.1.4. Manufacturing Technology Solutions

10. Cell and Gene Therapy Manufacturing Services Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Academic Institutions
    • 10.1.5. Research Institutions

11. Cell and Gene Therapy Manufacturing Services Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cell and Gene Therapy Manufacturing Services Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Adaptimmune Therapeutics plc
    • 12.2.2. Bluebird Bio, Inc.
    • 12.2.3. Catalent, Inc.
    • 12.2.4. Celyad Oncology SA
    • 12.2.5. Charles River Laboratories International, Inc.
    • 12.2.6. Gene Therapy Research Group
    • 12.2.7. Kiadis Pharma N.V.
    • 12.2.8. Lonza Group AG
    • 12.2.9. MaxCyte, Inc.
    • 12.2.10. Miltenyi Biotec GmbH
    • 12.2.11. Orchard Therapeutics plc
    • 12.2.12. Rocket Pharmaceuticals, Inc.
    • 12.2.13. Sangamo Therapeutics, Inc.
    • 12.2.14. Sarepta Therapeutics, Inc.
    • 12.2.15. TCR2 Therapeutics Inc.
    • 12.2.16. WuXi AppTec
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Therapy Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy Type
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Therapy Type 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Cell Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Cell Type 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Service Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Service Type
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Service Type 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by End-User 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Region 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Cell and Gene Therapy Manufacturing Services Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Therapy Type segment market share analysis, 2023 & 2032
  • FIGURE Therapy Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Cell Type segment market share analysis, 2023 & 2032
  • FIGURE Cell Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Service Type segment market share analysis, 2023 & 2032
  • FIGURE Service Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Europe Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Asia Pacific Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Latin America Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE Germany Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE India Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE Brazil Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE Saudi Arabia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)